🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fabienne Thomas

Inserm

ORCID: 0000-0001-9886-412X

Also affiliated with Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud

MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of Pharmacogenetics.

2 citations

Fabienne Thomas, A. Alyasiri, J. W. Fleshman, Alison A. Motsinger‐Reif, R. J. Myerson +5 more

0 citations

Barbara A. Zehnbauer, James W. Fleshman, Fabienne Thomas, Robert J. Myerson, Amer Alyasiry +6 more